Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Jan;37(1):14–18. doi: 10.1128/aac.37.1.14

Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.

A L Barry 1, P C Fuchs 1, M A Pfaller 1
PMCID: PMC187597  PMID: 8431012

Abstract

In in vitro studies we evaluated the susceptibilities of beta-lactamase-producing and -nonproducing, ampicillin-resistant strains of Haemophilus influenzae and compared them with those of ampicillin-susceptible strains. Ampicillin, amoxicillin-clavulanic acid, ceftibuten, cefaclor, cefuroxime, cefixime, and cefotaxime were evaluated by broth microdilution tests and disk diffusion tests. The disk diffusion tests accurately categorized beta-lactamase-producing strains and ampicillin-susceptible strains as being susceptible to the study drugs other than ampicillin. Ampicillin-resistant, beta-lactamase-nonproducing strains were relatively resistant to all seven study drugs, but the disk diffusion test did not always predict that resistance. The clinical relevance of the decreased susceptibility to various agents remains unclear, but to be conservative, all ampicillin-resistant, beta-lactamase-nonproducing strains might be assumed to be resistant to other beta-lactams. After excluding that small group of isolates, reliable susceptibility test results were obtained with lots of Haemophilus Test Medium that met quality assurance criteria.

Full text

PDF
14

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry A. L., Jones R. N. Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group. J Clin Microbiol. 1990 Mar;28(3):605–607. doi: 10.1128/jcm.28.3.605-607.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barry A. L., Jorgensen J. H., Hardy D. J., Allen S. D., Baker C. N. Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactams. J Clin Microbiol. 1992 Aug;30(8):2033–2037. doi: 10.1128/jcm.30.8.2033-2037.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barry A. L., Packer R. R. Performance of Haemophilus Test Media prepared with 12 different lots of Mueller-Hinton agar from four manufacturers. J Clin Microbiol. 1992 May;30(5):1145–1147. doi: 10.1128/jcm.30.5.1145-1147.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Doern G. V., Jorgensen J. H., Thornsberry C., Preston D. A., Tubert T., Redding J. S., Maher L. A. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother. 1988 Feb;32(2):180–185. doi: 10.1128/aac.32.2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Heelan J. S., Chesney D., Guadagno G. Investigation of ampicillin-intermediate strains of Haemophilus influenzae by using the disk diffusion procedure and current National Committee for Clinical Laboratory Standards guidelines. J Clin Microbiol. 1992 Jul;30(7):1674–1677. doi: 10.1128/jcm.30.7.1674-1677.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jones R. N., Barry A. L. Ceftibuten (7432-S, SCH 39720): comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines. Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):802–807. doi: 10.1007/BF01975055. [DOI] [PubMed] [Google Scholar]
  7. Jones R. N., Erwin M. E. False resistance results using 5 micrograms cefixime disks to test Haemophilus influenzae. Eur J Clin Microbiol Infect Dis. 1991 Jul;10(7):596–597. doi: 10.1007/BF01967284. [DOI] [PubMed] [Google Scholar]
  8. Jorgensen J. H., Barry A. L., Doern G. V., Ferraro M. J., Murray P. R. Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain. J Clin Microbiol. 1992 Aug;30(8):2029–2032. doi: 10.1128/jcm.30.8.2029-2032.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jorgensen J. H., Doern G. V., Maher L. A., Howell A. W., Redding J. S. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother. 1990 Nov;34(11):2075–2080. doi: 10.1128/aac.34.11.2075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jorgensen J. H., Redding J. S., Maher L. A., Howell A. W. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. J Clin Microbiol. 1987 Nov;25(11):2105–2113. doi: 10.1128/jcm.25.11.2105-2113.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mendelman P. M., Chaffin D. O., Clausen C., Stull T. L., Needham C., Williams J. D., Smith A. L. Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob Agents Chemother. 1986 Aug;30(2):274–280. doi: 10.1128/aac.30.2.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mendelman P. M., Chaffin D. O., Krilov L. R., Kalaitzoglou G., Serfass D. A., Onay O., Wiley E. A., Overturf G. D., Rubin L. G. Cefuroxime treatment failure of nontypable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteins. J Infect Dis. 1990 Nov;162(5):1118–1123. doi: 10.1093/infdis/162.5.1118. [DOI] [PubMed] [Google Scholar]
  13. Mendelman P. M., Chaffin D. O., Stull T. L., Rubens C. E., Mack K. D., Smith A. L. Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother. 1984 Aug;26(2):235–244. doi: 10.1128/aac.26.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mendelman P. M., Henritzy L. L., Chaffin D. O., Lent K., Smith A. L., Stull T. L., Wiley E. A. In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother. 1989 Nov;33(11):1878–1882. doi: 10.1128/aac.33.11.1878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mendelman P. M., Wiley E. A., Stull T. L., Clausen C., Chaffin D. O., Onay O. Problems with current recommendations for susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother. 1990 Aug;34(8):1480–1484. doi: 10.1128/aac.34.8.1480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Needham C. A. Haemophilus influenzae: antibiotic susceptibility. Clin Microbiol Rev. 1988 Apr;1(2):218–227. doi: 10.1128/cmr.1.2.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Powell M., McVey D., Kassim M. H., Chen H. Y., Williams J. D. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa. J Antimicrob Chemother. 1991 Aug;28(2):249–259. doi: 10.1093/jac/28.2.249. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES